Arlene Morris

Track

Insider profile

Currently holds positions in Neovacs SA, Palatin Technologies Inc, Viveve Medical Inc, Viridian Therapeutics Inc and Cogent Biosciences, Inc.

Positions

Position Company Period
Independent Director Neovacs SA May 4, 2011 -
Independent Director Palatin Technologies Inc June 1, 2015 -
Independent Director Viveve Medical Inc Jan. 1, 2017 -
Independent Director Viridian Therapeutics Inc Jan. 3, 2018 -
Independent Director Cogent Biosciences, Inc. July 26, 2019 -
Independent Director Dimension Therapeutics Inc Aug. 1, 2015 - Nov. 7, 2017
Director Viveve Medical Inc May 11, 2016 - Jan. 1, 2017
Director Albireo Pharma Inc May 15, 2015 - Nov. 3, 2016
President, Chief Executive Officer, Director Syndax Pharmaceuticals, Inc. Sept. 1, 2013 - May 12, 2015
Chief Executive Officer, Director Syndax Pharmaceuticals, Inc. March 1, 2012 - Sept. 1, 2013
Independent Director MediciNova Inc May 1, 2006 - June 14, 2013
Director Syndax Pharmaceuticals, Inc. May 1, 2011 - March 1, 2012
Arlene Morris's trades of Cogent Biosciences, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
480.82
Quantity 88,126
Value US$3,953,429
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-31 2026-08-27
PlS Planned sale
16,585 -6.2%
85.04
US$2,522,315 		16,585 -6.2% 85.04 US$2,522,315
2026-08-31 2026-08-27
PlS Planned sale
8,509 -28.6%
106.60
US$159,648 		8,509 -28.6% 106.60 US$159,648
2026-08-27 2026-08-27
PrS Proposed sale
88,126
480.82
US$3,953,429 		88,126 480.82 US$3,953,429